title: Caspofungin kills Candida albicans by causing both cellular apoptosis and necrosis.
abstract: Caspofungin exerts candidacidal activity by inhibiting cell wall (1,3)-β-d-glucan synthesis. We investigated the physiologic mechanisms of caspofungin-induced Candida albicans cell death. Apoptosis (programmed cell death) and necrosis were studied after C. albicans SC5314 cells were exposed to caspofungin at 0.06, 0.125, and 0.5 μg/ml (0.5×, 1×, and 4× the MIC, respectively) for 3 h. Caspofungin at 0.125 and 0.5 μg/ml reduced cellular viability by >50%, as measured by colony counts and methylene blue exclusion. Apoptosis and necrosis were demonstrated by annexin V and propidium iodide staining for phosphatidylserine externalization and loss of membrane integrity, respectively. At all concentrations of caspofungin, 20 to 25% and 5 to 7% of C. albicans cells exhibited early apoptosis and late apoptosis/necrosis, respectively (P value was not significant [NS]). Necrosis, on the other hand, was significantly greater at 0.125 (43%) and 0.5 (48%) μg/ml than at 0.06 μg/ml (26%) (P values of 0.003 and 0.003, respectively). The induction of apoptosis at concentrations less than or equal to the MIC was corroborated by dihydrorhodamine 123 (DHR-123) and dihydroethidium (DHE) staining (reactive oxygen species production), JC-1 staining (mitochondrial membrane potential dissipation), and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) and 4',6-diamidino-2-phenylindole dihydrochloride (DAPI) staining (DNA damage and nuclear fragmentation). Moreover, electron microscopy of cells exposed to 0.125 μg/ml of caspofungin showed hallmark apoptotic features like chromatin margination and condensation and nuclear blebs. Apoptosis was associated with metacaspase 1 activation, as demonstrated by D2R staining. Caspofungin exerts activity against C. albicans by directly killing cells (resulting in necrosis) and causing others to undergo programmed cell death (apoptosis). Apoptosis is initiated at subinhibitory concentrations, suggesting that strategies to target this process may augment the benefits of antifungal agents.
authors.affiliation: University of Pittsburgh and VA Pittsburgh Health System, Pittsburgh, Pennsylvania, USA.
authors.forename: Binghua
authors.initials: B
authors.lastname: Hao
authors.forename: Shaoji
authors.initials: S
authors.lastname: Cheng
authors.forename: Cornelius J
authors.initials: CJ
authors.lastname: Clancy
authors.forename: M Hong
authors.initials: MH
authors.lastname: Nguyen
mesh_terms: D017304:Annexin A5; D000935:Antifungal Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D002176:Candida albicans / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D000077336:Caspofungin; D002462:Cell Membrane / Q000187:drug effects / Q000648:ultrastructure; D015169:Colony Count, Microbial; D004305:Dose-Response Relationship, Drug; D054714:Echinocandins / Q000494:pharmacology*; D004996:Ethidium / Q000031:analogs & derivatives; D020287:In Situ Nick-End Labeling; D007211:Indoles; D055666:Lipopeptides; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D008751:Methylene Blue; D050296:Microbial Viability / Q000187:drug effects; D008854:Microscopy, Electron; D008928:Mitochondria / Q000187:drug effects* / Q000648:ultrastructure; D009336:Necrosis / Q000473:pathology*; D010718:Phosphatidylserines; D011419:Propidium; D017382:Reactive Oxygen Species / Q000378:metabolism; D012235:Rhodamines
chemical_list: D017304:Annexin A5; D000935:Antifungal Agents; D054714:Echinocandins; D007211:Indoles; D055666:Lipopeptides; D010718:Phosphatidylserines; D017382:Reactive Oxygen Species; D012235:Rhodamines; C067883:dihydroethidium; C058319:dihydrorhodamine 123; D011419:Propidium; C007293:DAPI; D004996:Ethidium; D000077336:Caspofungin; D008751:Methylene Blue